Advances in Pharmacoepidemiology and Drug Safety

Soo Jin Seung

Publications

• Research Article
  Etanercept Patient Assistance Program: Another Data Source for Epidemiological Studies?
  Author(s): Brian C Chan, Soo Jin Seung, David McLean, Mary Bell, Neil H Shear and Nicole Mittmann Brian C Chan, Soo Jin Seung, David McLean, Mary Bell, Neil H Shear and Nicole Mittmann
  
  Background: Patient assistance programs (PAP) have been established for biologic disease modifying therapies such as etanercept to improve patient knowledge and compliance and provide a means for follow-up. The information collected through these programs is a potential data source to determine patient characteristics, patient outcomes, treatment adherence and reimbursement practices of individuals prescribed biologic disease modifying therapies. Objective: To describe the population enrolled in the Enliven® Services Patient Assistance Program and to determine one-year retention rates. Methods: A retrospective review of a Canadian cohort of patients enrolled in an etanercept PAP diagnosed with rheumatoid arthritis (RA) was conducted. Demographic and utilization information was collected for all subjects enrolled in the period between 2000 and 2007. One-year ret.. View More»
  DOI: 10.4172/2167-1052.1000132

  Abstract PDF